NusaTrip Announces Receipt of Delisting Notice from Nasdaq
NusaTrip said it received Nasdaq’s delisting determination on August 3, 2026 and will not appeal, instead seeking over-the-counter trading. The move removes the Nasdaq listing and leaves NTRP facing a materially weaker trading venue despite reported revenue growth, while the enrichment shows negative diluted EPS and limited operating scale.
What happened
NusaTrip said it received Nasdaq’s delisting determination on August 3, 2026 and will not appeal, instead seeking over-the-counter trading.
The read · Aug 11
The delisting decision moves the risk to the downside for NTRP as the company accepts OTC trading despite $3.7M of revenue and 641.0% YoY growth, with diluted EPS at $-1.82.
Wrong if
The setup weakens if NusaTrip reverses the delisting process or secures continued Nasdaq trading, while the reported 641.0% YoY revenue growth could also attract enough demand to offset the OTC transition.
CoverageSource: GlobeNewswire · Published here TUE, AUG 11 · 9:20 AM ET · the only report in this recordHow this is decided →
The chart · NTRPTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
NusaTrip announced that it received a Nasdaq Staff Delisting Determination on August 3, 2026. The company said it will not appeal the decision and plans to seek over-the-counter trading instead.
The immediate consequence is the loss of NusaTrip’s Nasdaq listing, shifting the company toward a less liquid and less visible trading venue. NTRP reported revenue of $3.7M, up 641.0% YoY, but its diluted EPS was $-1.82, so the headline growth does not remove the listing and profitability concerns.
The enrichment also shows 17.6% gross margins and 437.3% net margins, a combination that is difficult to interpret without further context and does not offset the negative diluted EPS. The central setup is therefore the contrast between rapid reported revenue growth and the trading, liquidity, and compliance consequences of delisting.
NTRP’s decision not to appeal removes a potential near-term route to preserving its Nasdaq status. The next points to watch are the timing and mechanics of the OTC transition, along with the company’s ability to sustain revenue growth and address its negative earnings profile.
The read, in fullWhy it matters
NTRP will not appeal Nasdaq’s delisting determination and plans to move to over-the-counter trading, creating a concrete venue and liquidity overhang. The reported $3.7M of revenue and 641.0% YoY growth are notable, but diluted EPS of $-1.82 leaves the operating profile less able to counter the delisting impact.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written
Next · what would move this
Tactical / 2-4 weeks. Follow to be told when one lands.
▲ The case it holds
The strongest bull case is the $3.7M revenue base and 641.0% YoY growth, which could support the company if that growth proves durable after the listing change.
▼ The case it breaks
The bear case is stronger: NusaTrip will not appeal the delisting determination, is moving toward OTC trading, and reported diluted EPS of $-1.82, leaving a direct liquidity and earnings overhang.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
STOCK PHOTO · ARTEM PODREZ